Curis to Present Updated Data from the TakeAim Leukemia Study

Go back to Curis to Present Updated Data from the TakeAim Leukemia Study
Curis, Inc. (NASDAQ: CRIS) Delayed: 1.18 +0.02 (1.72%)
Previous Close $1.16    52 Week High $3.70 
Open $1.18    52 Week Low $1.25 
Day High $1.19    P/E N/A 
Day Low $1.15    EPS $-0.15 
Volume 10,778